BamSEC and AlphaSense Join Forces
Learn More

Praecis Pharmaceuticals Inc

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 60 pages Confidential Information Omitted and Filed Separately With the Securities and Exchange Commission. Asterisks (*) Denote Such Omissions
12/34/56
EX-10.4
from 10-Q 14 pages Article 1 Definitions
12/34/56
EX-10.20
from 10-K 5 pages Settlement Agreement and Mutual General Release
12/34/56
EX-10.18
from 10-K 4 pages Confidential Information Omitted and Filed Separately With the Securities and Exchange Commission. Asterisks (*) Denote Such Omissions. Letter Agreement
12/34/56
EX-10.12
from 10-K 3 pages Summary of 2006 Compensation for Executive Officers, Non-Executive Chairman and Non-Employee Directors
12/34/56
EX-10.2
from 10-Q 70 pages Lease by and Between Intercontinental Fund III 830 Winter Street LLC, as Landlord and Praecis Pharmaceuticals Incorporated, as Tenant With Respect to Property Located at 830 Winter Street, Waltham, Massachusetts October 18, 2005
12/34/56
EX-10.1
from 10-Q 27 pages Real Estate Purchase Agreement Between 830 Winter Street LLC as Seller and Intercontinental Real Estate Investment Fund III, LLC as Purchaser of 830 Winter Street, Waltham, Massachusetts
12/34/56
EX-10.1
from 10-Q 9 pages Praecis Pharmaceuticals Incorporated Second Amended and Restated Employee Stock Purchase Plan
12/34/56
EX-10.18
from 10-K 3 pages Summary of 2005 Compensation for Executive Officers and Non-Employee Directors
12/34/56
EX-10.17
from 10-K 7 pages Material contract
12/34/56
EX-10.5
from 10-Q 5 pages Confidential Information Omitted and Filed Separately With the Securities and Exchange Commission. Asterisks (*) Denote Such Omissions. Amendment No. 2 Dated as of August 30, 2004 (This “Amendment”) to the Development and Supply Agreement Concluded Between Ucb S.A. and Amgen Inc. (Thereafter Assigned to Praecis Pharmaceuticals Incorporated) Dated June 21, 2000
12/34/56
EX-10.2
from 10-Q 6 pages Praecis Pharmaceuticals Incorporated Form of Non-Qualified Stock Option Agreement
12/34/56
EX-10.1
from 10-Q 8 pages Praecis Pharmaceuticals Incorporated Form of Incentive Stock Option Agreement
12/34/56
EX-10.6
from 10-Q 6 pages First Amendment to and Reaffirmation of Environmental Compliance and Indemnity Agreement
12/34/56
EX-10.5
from 10-Q 6 pages First Amendment to and Reaffirmation of Guaranty of Non-Recourse Exceptions
12/34/56
EX-10.3
from 10-Q 10 pages Confidential Information Omitted and Filed Separately With the Securities and Exchange Commission. Asterisks (*) Denote Such Omissions. Amendment No. 2 to Supply Agreement
12/34/56
EX-10.2
from 10-Q 52 pages Confidential Information Omitted and Filed Separately With the Securities and Exchange Commission. Asterisks (*) Denote Such Omissions. License, Supply and Distribution Agreement
12/34/56
EX-10.1
from 10-Q 2 pages Material contract
12/34/56
EX-10.17
from 10-K ~50 pages Material contract
12/34/56
EX-10.6
from 10-K 1 page Material contract
12/34/56